Disposition of 18375 shares by Wright Richard M. of Celldex Therapeutics at 22.48 subject to Rule 16b-3

CLDX Stock  USD 26.58  0.36  1.37%   
Slightly above 60% of Celldex Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Celldex Therapeutics suggests that many traders are alarmed. Celldex Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Celldex Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Celldex Therapeutics Officer Sr. Vp Cco. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 18375 incentive stock option (right to buy) at 22.48 of Celldex Therapeutics by Wright Richard M. on 23rd of September 2024. This event was filed by Celldex Therapeutics with SEC on 2024-06-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Celldex Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Celldex Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Celldex Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Celldex Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Celldex Therapeutics Historical Investor Sentiment

Investor biases related to Celldex Therapeutics' public news can be used to forecast risks associated with an investment in Celldex. The trend in average sentiment can be used to explain how an investor holding Celldex can time the market purely based on public headlines and social activities around Celldex Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Celldex Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Celldex Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Celldex Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Celldex Therapeutics.

Celldex Therapeutics Fundamental Analysis

We analyze Celldex Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celldex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celldex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Celldex Therapeutics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Celldex Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celldex Therapeutics stock to make a market-neutral strategy. Peer analysis of Celldex Therapeutics could also be used in its relative valuation, which is a method of valuing Celldex Therapeutics by comparing valuation metrics with similar companies.

Peers

Celldex Therapeutics Related Equities

ANABAnaptysBio   9.45   
0%
100.0%
KROSKeros Therapeutics   8.85   
0%
93.0%
IDYAIdeaya Biosciences   6.34   
0%
67.0%
VTYXVentyx Biosciences   6.12   
0%
64.0%
DYNDyne Therapeutics   4.51   
0%
47.0%
DAWNDay One   1.55   
0%
16.0%
BCABBioatla   1.26   
0%
13.0%
CRNXCrinetics Pharmaceuticals   0.92   
0%
9.0%
ALXOAlx Oncology   0.65   
0%
6.0%
MGTXMeiraGTx Holdings   0.48   
0%
5.0%
EWTXEdgewise Therapeutics   0.31   
0%
3.0%
COGTCogent Biosciences   0.22   
0%
2.0%
RVMDRevolution Medicines   0.04   
0%
1.0%
TVTXTravere Therapeutics   0.05   
1.0%
0%
SWTXSpringWorks Therapeutics   0.56   
5.0%
0%
IMTXImmatics   1.12   
11.0%
0%
RNAAvidity Biosciences   1.43   
15.0%
0%
CYTKCytokinetics   2.08   
22.0%
0%
AVTEAerovate Therapeutics   2.67   
28.0%
0%

Additional Tools for Celldex Stock Analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.